Epstein David H, Preston Kenzie L, Stewart Jane, Shaham Yavin
Clinical Pharmacology and Therapeutics Research Branch, IRP/NIDA/NIH/DHHS, Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2006 Nov;189(1):1-16. doi: 10.1007/s00213-006-0529-6. Epub 2006 Sep 22.
The reinstatement model is widely used to study relapse to drug addiction. However, the model's validity is open to question.
We assess the reinstatement model in terms of criterion and construct validity.
We find that the reinstatement model has adequate criterion validity in the broad sense of the term, as evidenced by the fact that reinstatement in laboratory animals is induced by conditions reported to provoke relapse in humans. The model's criterion validity in the narrower sense, as a medication screen, seems promising for relapse to heroin, nicotine, and alcohol. For relapse to cocaine, criterion validity has not yet been established primarily because clinical studies have examined medication's effects on reductions in cocaine intake rather than relapse during abstinence. The model's construct validity faces more substantial challenges and is yet to be established, but we argue that some of the criticisms of the model in this regard may have been overstated.
复吸模型被广泛用于研究药物成瘾的复发。然而,该模型的有效性存在疑问。
我们从标准效度和结构效度方面评估复吸模型。
我们发现,复吸模型在广义上具有足够的标准效度,这一点可由以下事实证明:实验室动物的复吸是由据报道会引发人类复吸的条件所诱发的。作为一种药物筛选方法,该模型在狭义上的标准效度对于海洛因、尼古丁和酒精成瘾的复吸似乎很有前景。对于可卡因成瘾的复吸,标准效度尚未确立,主要是因为临床研究考察的是药物对减少可卡因摄入量的影响,而非戒断期间的复吸情况。该模型的结构效度面临更严峻的挑战,尚未确立,但我们认为在这方面对该模型的一些批评可能有些夸大。